Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
Authors:
- Jiawen YangJYJiawen Yang
- James T. LimJLJames T. Lim
- Marcelo G. CoronaMCMarcelo G. Corona
- Chen ChenCCChen Chen
- Hunain KhawajaHKHunain Khawaja
- Qiong PanQPQiong Pan
- Gillian D. Paine-MurrietaGPGillian D. Paine-Murrieta
- Rick G. SchnellmannRSRick G. Schnellmann
- Denise J. RoeDRDenise J. Roe
- Prafulla C. GokhalePGPrafulla C. Gokhale
- James A. DeCaprioJDJames A. DeCaprio
Open Access
- 11 February 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (7)
Abstract
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cutaneous malignancy arising from either ultraviolet-induced mutagenesis or Merkel cell polyomavirus (MCPyV) integration. Despite extensive research, our understanding of the molecular mechanisms driving the transition from normal cells to MCC remains limited. To address this knowledge gap, we assessed the impact of inducible MCPyV T antigens on normal human fibroblasts by performing RNA-seq. Our data uncovered changes in expression and regulation of Wnt signaling pathway members. Building on this observation, we bioinformatically evaluated various Wnt pathway perturbagens for their ability to reverse the MCC gene expression signature and identified pyrvinium pamoate, an FDA-approved anthelminthic drug known for its antitumor activity in other cancers. Leveraging transcriptomic, network, and molecular analyses, we found that pyrvinium targets multiple MCC vulnerabilities. Pyrvinium not only reverses the neuroendocrine features of MCC by modulating canonical and noncanonical Wnt signaling but also inhibits cancer cell growth by activating p53-mediated apoptosis, disrupting mitochondrial function, and inducing endoplasmic reticulum stress. Finally, we demonstrated that pyrvinium reduces tumor growth in an MCC mouse xenograft model. These findings offer a deeper understanding of the role of Wnt signaling in MCC and highlight the utility of pyrvinium as a potential treatment for MCC.Keywords
All Related Versions
This publication has 78 references indexed in Scilit:
- A Central Role for CK1 in Catalyzing Phosphorylation of the p53 Transactivation Domain at Serine 20 after HHV-6B Viral InfectionJournal of Biological Chemistry, 2008
- Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinomaLaboratory Investigation, 2008
- The Wnt‐signaling pathway is not implicated in tumorigenesis of Merkel cell carcinomaJournal of Cutaneous Pathology, 2006
- Antitumor activity of pyrvinium pamoate, 6‐(dimethylamino)‐2‐[2‐(2,5‐dimethyl‐1‐phenyl‐1H‐pyrrol‐3‐yl)ethenyl]‐1‐methyl‐quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvationCancer Science, 2004
- Wnt5a signaling directly affects cell motility and invasion of metastatic melanomaCancer Cell, 2002
- Mutant p53: Gain-of-Function Oncoproteins and Wild-Type p53 InactivatorsBiological Chemistry, 1999
- MECHANISMS OF WNT SIGNALING IN DEVELOPMENTAnnual Review of Cell and Developmental Biology, 1998
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Wnt genesCell, 1992